Acrivon executives cover taxes with 1,743 shares
Acrivon Therapeutics executives reported routine tax-related share dispositions tied to restricted stock unit vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Acrivon Therapeutics executives reported routine tax-related share dispositions tied to restricted stock unit vesting. A total of 1,743 common shares at $1.92 were withheld by the company to satisfy mandatory tax obligations, rather than sold in the open market.
After these withholdings, one executive directly holds 2,078,951 shares and another has 313,637 shares reported as indirectly held through spousal ownership, reflecting that both retain substantial positions following the transactions.
Insider Trade Summary
Exercise Price or Tax Liability: 1,743 shares
Exercise Price or Tax Liability
2 txns
Insider
Blume-Jensen Peter, Masson Kristina
Role
President and CEO | EVP - Business Operations
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 1,253 | $1.92 | $2K |
| Exercise Price or Tax Liability | Common Stock | 490 | $1.92 | $940.80 |
Holdings After Transaction:
Common Stock — 2,078,951 shares (Direct);
Common Stock — 313,637 shares (Indirect, See Footnote)
Footnotes (3)
- F1. Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
- F2. These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.
- F3. These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Tax-withheld shares: 1,743 shares
Withholding price: $1.92 per share
Direct holdings after transaction: 2,078,951 shares
+2 more
5 metrics
Tax-withheld shares
1,743 shares
Common stock withheld for tax on RSU vesting
Withholding price
$1.92 per share
Value used for tax-withholding dispositions
Direct holdings after transaction
2,078,951 shares
Common stock directly held by one executive after tax withholding
Indirect holdings after transaction
313,637 shares
Common stock indirectly held through spousal ownership after withholding
Non-derivative transactions
2 dispositions
Both coded F for tax-withholding on RSUs
Key Terms
restricted stock units, mandatory tax withholding, beneficial ownership, pecuniary interest
4 terms
restricted stock units financial
"upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
mandatory tax withholding financial
"to satisfy the mandatory tax withholding requirement"
beneficial ownership financial
"disclaims beneficial ownership of such securities except"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of her pecuniary interest therein."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Acrivon Therapeutics (ACRV) insiders report in this Form 4?
Acrivon Therapeutics insiders reported that 1,743 common shares were withheld at $1.92 per share to cover tax obligations on vested restricted stock units, a standard administrative transaction rather than an open-market stock sale.
Were the Acrivon (ACRV) Form 4 transactions open-market stock sales?
No, the transactions were not open-market sales. The 1,743 Acrivon common shares were withheld by the company to satisfy mandatory tax withholding on restricted stock unit vesting, classified under code F as tax-withholding dispositions.
What does transaction code F mean in the Acrivon (ACRV) Form 4 filing?
Transaction code F in the Acrivon filing indicates shares were delivered to pay a tax liability or exercise price. Here, it reflects shares withheld by the issuer to meet mandatory tax withholding on restricted stock unit vesting, not discretionary stock sales.
How are spousal holdings treated in the Acrivon Therapeutics (ACRV) Form 4?
The Form 4 explains that each executive’s spouse holds some of the reported Acrivon shares. Each spouse disclaims beneficial ownership except for their pecuniary interest, meaning indirect holdings are reported with limited ownership claims per the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates